Searched for
AI FOR DIABETES MEAL PLANS
South Korea's SK Hynix eyes US listing as soon as August, sources sayThe US Securities and Exchange Commission is likely to approve SK Hynix's American depositary receipt listing application during the week...- Anthropic releases Fable 5, first public model from Mythos familyAnthropic, maker of the Claude artificial intelligence (AI) models, on Tuesday made the most powerful version of its technology available t...
- AGI for all among OpenAI’s ambitions for its next phaseOpenAI is entering a new phase to make advanced AI widely available and affordable. The company plans to build AI researchers to accelerate...
- Perplexity plans 2028 IPO regardless of Anthropic or OpenAI listings: ReportAI firm Perplexity plans to go public in 2028, irrespective of how Anthropic and OpenAI's IPOs perform. CEO Aravind Srinivas stated the 202...
- Perplexity plans 2028 IPO regardless of Anthropic or OpenAI listings, CNBC reportsOpenAI confidentially filed for a U.S. IPO earlier on Monday, following Anthropic's filing last week. Elon Musk's SpaceX is also preparing ...
- Stocks in news: Bharti Airtel, Vodafone Idea, NLC India, Motilal Oswal, HCL TechIndian markets saw a sharp decline on Monday amid global worries and geopolitical tensions. Nifty moved closer to a key support level. Seve...
- Practo's CPTO shares how AI is changing his daily lifePracto's Srijesh K highlights the addictive nature of AI tools for building and testing. He shares how AI assists in personal tasks, from f...
- UK sets out $1.5 billion AI hardware plan with supercomputer, chip fundingBritain is investing over a billion pounds to boost its AI computing power. A new national supercomputer is planned for 2030. The country i...
- ET Most Innovative AI Product Awards 2026: Recognising AI innovations transforming the modern CFO officeThe ET Most Innovative AI Product Awards 2026 recognise AI-powered innovations helping Chief Financial Officers move beyond reporting and c...
- SpaceX IPO: Elon Musk's AI ambitions fueling space data centers & trillionaire dreamsSpaceX's upcoming IPO, fueled by immense investor demand, could propel Elon Musk to trillionaire status. Beyond its space ambitions, the co...
- OpenAI plans ChatGPT 'superapp' overhaul ahead of listing, FT reportsThe changes are part of a broader reorganisation at OpenAI, as it shifts resources to target lucrative enterprise clients and intensify co...
- The Chennai-born architect behind Trump’s AI push is leaving the White HouseIn a noteworthy development, Sriram Krishnan, an influential strategist behind Donald Trump's AI agenda, will be leaving his position at th...
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
- Union minister Piyush Goyal launches skill, AI employment initiatives in MumbaiIn a significant push towards building a future-ready workforce for Viksit Bharat 2047, Uttar Mumbai MP and Union Commerce Minister Piyush ...
- In 1889, a physician noticed a sweet urine clue and helped point medicine toward insulinIn a groundbreaking moment in 1889, two German scientists, Joseph von Mering and Oskar Minkowski, uncovered a crucial link between the panc...
- Nayara Energy completes scheduled Vadinar refinery turnaroundNayara Energy has finished its scheduled maintenance at the Vadinar refinery. This critical work involved thousands of personnel and heavy ...
- Heat waves demand more than just water for proper hydration; electrolytes intake necessary: ExpertsHealth experts warn that during heat waves, water alone is not enough for hydration. Excessive sweating depletes essential electrolytes lik...
- 30-day transformation plan goes viral: Fitness trainer shares simple rules for fast fat loss and better healthFitness trainer Takai Raashid presents a 30-day, 15-pound weight loss program emphasizing a calorie deficit, high protein intake, and consi...
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
Load More
